Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
Standard
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018). / Schnürch, Hans-Georg; Ackermann, Sven; Alt-Radtke, Celine D; Angleitner, Lukas; Barinoff, Jana; Beckmann, Matthias W; Böing, Carsten; Dannecker, Christian; Fehm, Tanja; Gaase, Rüdiger; Gass, Paul; Gebhardt, Marion; Gieseking, Friederike; Günthert, Andreas; Hack, Carolin C; Hantschmann, Peer; Horn, Lars Christian; Koch, Martin C; Letsch, Anne; Mallmann, Peter; Mangold, Bernhard; Marnitz, Simone; Mehlhorn, Grit; Paradies, Kerstin; Reinhardt, Michael J; Tholen, Reina; Torsten, Uwe; Weikel, Wolfgang; Wölber, Linn; Hampl, Monika.
In: GEBURTSH FRAUENHEILK, Vol. 79, No. 10, 10.2019, p. 1060-1078.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
AU - Schnürch, Hans-Georg
AU - Ackermann, Sven
AU - Alt-Radtke, Celine D
AU - Angleitner, Lukas
AU - Barinoff, Jana
AU - Beckmann, Matthias W
AU - Böing, Carsten
AU - Dannecker, Christian
AU - Fehm, Tanja
AU - Gaase, Rüdiger
AU - Gass, Paul
AU - Gebhardt, Marion
AU - Gieseking, Friederike
AU - Günthert, Andreas
AU - Hack, Carolin C
AU - Hantschmann, Peer
AU - Horn, Lars Christian
AU - Koch, Martin C
AU - Letsch, Anne
AU - Mallmann, Peter
AU - Mangold, Bernhard
AU - Marnitz, Simone
AU - Mehlhorn, Grit
AU - Paradies, Kerstin
AU - Reinhardt, Michael J
AU - Tholen, Reina
AU - Torsten, Uwe
AU - Weikel, Wolfgang
AU - Wölber, Linn
AU - Hampl, Monika
N1 - © Thieme Medical Publishers.
PY - 2019/10
Y1 - 2019/10
N2 - Purpose This is an official guideline, published and coordinated by the Gynecological Oncology Working Group (AGO) of the German Cancer Society (DKG) and the German Society for Gynecology and Obstetrics (DGGG). Vaginal cancers are rare tumors, which is why there is very little evidence on these tumors. Knowledge about the optimal clinical management is limited. This first German S2k guideline on vaginal cancer has aimed to compile the most current expert knowledge and offer new recommendations on the appropriate treatment as well as providing pointers about individually adapted therapies with lower morbidity rates than were previously generally available. The purpose of this guideline is also to set up a register to record data on treatment data and the course of disease as a means of obtaining evidence in future. Methods The present S2k guideline was developed by members of the Vulvar und Vaginal Tumors Commission of the AGO in an independently moderated, structured, formal consensus process and the contents were agreed with the mandate holders of the participating scientific societies and organizations. Recommendations To optimize the daily care of patients with vaginal cancer: 1. Monitor the spread pattern; 2. Follow the step-by-step diagnostic workup based on initial stage at detection; 3. As part of individualized clinical therapeutic management of vaginal cancer, follow the sentinel lymph node protocol described here, where possible; 4. Participate in the register study on vaginal cancer.
AB - Purpose This is an official guideline, published and coordinated by the Gynecological Oncology Working Group (AGO) of the German Cancer Society (DKG) and the German Society for Gynecology and Obstetrics (DGGG). Vaginal cancers are rare tumors, which is why there is very little evidence on these tumors. Knowledge about the optimal clinical management is limited. This first German S2k guideline on vaginal cancer has aimed to compile the most current expert knowledge and offer new recommendations on the appropriate treatment as well as providing pointers about individually adapted therapies with lower morbidity rates than were previously generally available. The purpose of this guideline is also to set up a register to record data on treatment data and the course of disease as a means of obtaining evidence in future. Methods The present S2k guideline was developed by members of the Vulvar und Vaginal Tumors Commission of the AGO in an independently moderated, structured, formal consensus process and the contents were agreed with the mandate holders of the participating scientific societies and organizations. Recommendations To optimize the daily care of patients with vaginal cancer: 1. Monitor the spread pattern; 2. Follow the step-by-step diagnostic workup based on initial stage at detection; 3. As part of individualized clinical therapeutic management of vaginal cancer, follow the sentinel lymph node protocol described here, where possible; 4. Participate in the register study on vaginal cancer.
U2 - 10.1055/a-0919-4959
DO - 10.1055/a-0919-4959
M3 - SCORING: Journal article
C2 - 31680701
VL - 79
SP - 1060
EP - 1078
JO - GEBURTSH FRAUENHEILK
JF - GEBURTSH FRAUENHEILK
SN - 0016-5751
IS - 10
ER -